ZD 7114
Alternative Names: ICI D 7114Latest Information Update: 06 May 2003
At a glance
- Originator AstraZeneca
- Class Thermogenics
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 06 May 2003 Discontinued - Clinical-Phase-Unknown for Obesity (unspecified route)
- 06 May 2003 Discontinued - Preclinical for Type-2 diabetes mellitus (unspecified route)
- 03 Oct 2001 No-Development-Reported for Obesity (Unknown route)